SHEETROCK First Coat

SECTION 2: Hazards identification

EMERGENCY OVERVIEW: ΔWARNING! This product is not expected to produce any unusual hazards during normal use. Exposure to high dust and/or mist levels may irritate the skin, eyes, nose, throat, or upper respiratory tract. Exposure to high vapor levels of ethylene glycol may cause slight headache, dizziness, nausea, drowsiness, and/or stupor. Prolonged and repeated breathing of respirable mica dust may cause lung disease (pneumoconiosis).

Potential health effects

(See Section 11 for more information) ACUTE Exposure to dust and mist generated during the handling, spray application or use of the product may cause temporary irritation to eyes, skin, nose, throat, and upper respiratory tract. Persons subjected to large amounts of this dust or mist will be forced to leave area because of nuisance conditions such as coughing, sneezing and nasal irritation. Labored breathing may occur after excessive inhalation. If Inhalation respiratory symptoms persist, consult physician. Breathing of ethylene glycol vapors can cause slight headache, dizziness, nausea, drowsiness, and/or stupor. Exposure to high vapor levels may irritate the nose, throat, or upper respiratory tract. Labored breathing may occur after excessive inhalation. If respiratory symptoms persist, consult physician. Dust/mist can cause temporary mechanical irritation of eyes. If burning, redness, itching, pain or other Eyes symptoms persist or develop, consult physician. Ethylene glycol vapors may cause slight temporary eye irritation. Skin None known. Ingestion None known. CHRONIC: Animal studies indicate that prolonged and repeated overexposure to ethylene glycol may cause kidney and/or liver damage and birth defects. Overexposure is highly unlikely at concentrations present in this product. Prolonged and repeated breathing of respirable mica dust may cause lung disease Inhalation (pneumoconiosis). The extent and severity of lung injury correlates with the length of exposure and dust concentration. Exposures to respirable crystalline silica are not expected during the normal use of this product; however, actual levels must be determined by workplace hygiene testing. Prolonged and repeated exposure to airborne free respirable crystalline silica can result in lung disease (i.e., silicosis) and/or lung cancer. The development of silicosis may increase the risks of additional health effects. The risk of developing silicosis is dependent upon the exposure intensity and duration. Eyes None known. Skin None known. Ingestion None known. TARGET ORGANS: Eyes, skin and respiratory system.

Principle Routes of Exposure

Inhalation, eyes and skin contact CARCINOGENICITY CLASSIFICATION OF INGREDIENT(S) All substances listed are associated with the nature of the raw materials used in the manufacture of this product and are not independent components of the product formulation. All substances, if present, are at levels well below regulatory limits. See Section 11: Toxicology Information for detailed information. MATERIAL IARC NTP ACGIH CAL- 65 Vinyl Acetate Monomer 2B Not Listed A3 Not Listed Acetaldehyde 2B 2 A3 Listed Formaldehyde 1 2 A2 Listed Titanium Dioxide 2B Not Listed A4 Not Listed 1,4 Dioxane 2B 2 A3 Listed Acetaldehyde 2B 2 A3 Listed Crystalline silica 1 A2 Listed IARC - International Agency for Research on Cancer: 1- Carcinogenic to humans; 2A – Probably carcinogenic to humans; 2B – Possibly carcinogenic to humans; 3 - Not classifiable as a carcinogen; 4 – Probably not a carcinogen NTP – National Toxicology Program (Health and Human Services Dept., Public Health Service, NIH/NIEHS): 1- Known to be carcinogen; 2- Anticipated to be carcinogens ACGIH – American Conference of Governmental Industrial Hygienists: A1 – Confirmed human carcinogen; A2 – Suspected human carcinogen; A3 – Animal carcinogen; A4 - Not classifiable as a carcinogen; A5 – Not suspected as a human carcinogen

Environmental effects

This product has no known adverse effect on ecology. (See Section 12 for more information.)